type-2

Documents about type-2

• Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age#143631ClinicalTrials.gov
• The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients#143755ClinicalTrials.gov
• Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment#146404ClinicalTrials.gov
• A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)#152358ClinicalTrials.gov
• Enhanced Thermoelectric Performance of P ‐Type (Bi,Sb) 2 Te 3 by Incorporating Non‐Stoichiometric Ag 5 Te 3 and Refining Te‐Se Ratio#153669HAL (France)
• Antidiabetic Effect of Olive Pomace Oil#160320ClinicalTrials.gov
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)#162405ClinicalTrials.gov
• Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake#172491ClinicalTrials.gov
• A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes.#174780NCBI PubMed Central
• Comparing the Effects of Lavender Aromatherapy With Virtual Reality on the Quality of Sleep in Type 2 Diabetic Patients: A Randomized Controlled Trial.#4118NCBI PubMed Central
• Metabolomic and proteomic signatures of gestational diabetes predicting long-term risk of type 2 diabetes: a prospective cohort study in the UK Biobank#5038Europe PMC
• Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets#18548ClinicalTrials.gov
• Immune cell-based clustering reveals clinically distinct endotypes in type 2 diabetes#124411HAL (France)
• Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF#127792ClinicalTrials.gov
• Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes#127835ClinicalTrials.gov
• Primary care providers' perspectives on the implementation of couple-based collaborative management for Chinese older adults with type 2 diabetes: a mixed-methods study.#138573NCBI PubMed Central
• Weight loss is associated with improved daytime time in range in adults with prediabetes and non-insulin-treated type 2 diabetes undergoing dietary intervention.#152199NCBI PubMed Central
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)#154856ClinicalTrials.gov
• Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules#158030ClinicalTrials.gov
• Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes#160259ClinicalTrials.gov
• A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY#172511ClinicalTrials.gov
• Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance#6909OpenAlex
• Single-cell RNA-seq and in vitro study reveal Fusobacterium nucleatum impairs β-cell identity in type 2 diabetes via the NF-κB-CDKN1C axis.#25715NCBI PubMed Central
• Clinical guidelines on physical activity and exercise therapy for Chinese adults with type 2 diabetes: A clinical practice guideline from the Chinese Society of Endocrinology.#30833NCBI PubMed Central
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease#67851ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers#123336Europe PMC
• Impact of PharmaTE trial on glycemic control, diabetes knowledge, medication adherence, and quality of life in type 2 diabetes patients: a mixed-methods study protocol.#125679NCBI PubMed Central
• Type I and III interferon responses restrict infection by tick-borne orthoflaviviruses through IFI6#129467HAL (France)
• Digital twin technologies for supporting self-care in adults with diet-related chronic conditions: a systematic review.#136095PubMed
• Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)#140943ClinicalTrials.gov
• Mitofusin MFN2 acts as a molecular sensor preventing protein aggregation and mitophagy, with a protective effect against apoptosis in Charcot–Marie–Tooth type 2A disease#145044HAL (France)
• Stable isotope data of sediment trap P83-2#150955DataCite
• The Laparoscopic Transit Bipartition With Use Metalic Anastomosis Clip#154834ClinicalTrials.gov
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes#158161ClinicalTrials.gov
• A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects#172507ClinicalTrials.gov
• Breaking the cycle: patient activation role in improving diabetes self-care adherence for alleviating diabetes distress.#9961PubMed
• Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study#13222HAL (France)
• Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study#14222HAL (France)
• Correlation Analysis of 24-h Minimum Heart Rate Levels and Deceleration Capacity of Heart Rate in Patients With Type 2 Diabetes Mellitus Complicated With Essential Hypertension.#28246NCBI PubMed Central
• A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions#126029ClinicalTrials.gov
• PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program#126047ClinicalTrials.gov
• Translation, Cultural Adaptation, and Psychometric Validation of the McMaster Family Assessment Device's General Functioning Subscale: A Cross-Sectional Study Among African Adults With Type 2 Diabetes.#143054NCBI PubMed Central
• Development and internal validation of a machine learning-based model to predict 1-year all-cause mortality in patients with gastrointestinal bleeding with type 2 diabetes.#154319NCBI PubMed Central
• A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality-Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns.#159993NCBI PubMed Central
• Effectiveness of behavioural economics-based financial incentives and social feedback on glycaemic control and physical activity in adults with newly diagnosed type 2 diabetes: A randomised control trial.#9247NCBI PubMed Central
• Influence of Heat Flow Meter sensor type on the thermal conductance measured in presence of vapor flow#121918HAL (France)
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.#123408ClinicalTrials.gov
• Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study#130661Springer Nature OA
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.#140968ClinicalTrials.gov